CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-11 | Turner Kathy V Senior Vice President | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −8,567 | 1,581 | ||
| 2022-11-10 | Turner Kathy V Senior Vice President | Exercise or conversion | +5,310 | $206.94 | $1.1M | 12,233.39 |
| 2022-11-10 | Turner Kathy V Senior Vice President | Sale | −2,655 | $410.02 | $1.1M | 9,578.39 |
| 2022-11-10 | Turner Kathy V Senior Vice President | Sale | −25 | $406.11 | $10K | 9,553.39 |
| 2022-11-10 | Turner Kathy V Senior Vice President | Sale | −2,630 | $405.21 | $1.1M | 6,923.39 |
| 2022-11-10 | Turner Kathy V Senior Vice President | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −5,310 | 3,056 | ||
| 2022-11-09 | AYERS JONATHAN W Director | Gift | −5,000 | 170,420 | ||
| 2022-11-07 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion | +24,002 | $52.00 | $1.2M | 75,536.64 |
| 2022-11-07 | MAZELSKY JONATHAN JAY President & CEO | Sale | −900 | $378.60 | $341K | 74,636.64 |
| 2022-11-07 | MAZELSKY JONATHAN JAY President & CEO | Sale | −2,000 | $379.50 | $759K | 72,636.64 |
| 2022-11-07 | MAZELSKY JONATHAN JAY President & CEO | Sale | −500 | $380.85 | $190K | 72,136.64 |
| 2022-11-07 | MAZELSKY JONATHAN JAY President & CEO | Sale | −3,704 | $382.81 | $1.4M | 68,432.64 |
| 2022-11-07 | MAZELSKY JONATHAN JAY President & CEO | Sale | −2,716 | $383.29 | $1.0M | 65,716.64 |
| 2022-11-07 | MAZELSKY JONATHAN JAY President & CEO | Sale | −3,018 | $384.47 | $1.2M | 62,698.64 |
| 2022-11-07 | MAZELSKY JONATHAN JAY President & CEO | Sale | −392 | $385.01 | $151K | 62,306.64 |
| 2022-11-07 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −24,002 | 0 | ||
| 2022-10-28 | JUNIUS DANIEL M Director | Grant or award | +18 | $364.28 | $7K | 2,968 |
| 2022-09-06 | AYERS JONATHAN W Director | Gift | −450,000 | 175,420 | ||
| 2022-09-06 | AYERS JONATHAN W Director | Gift | +450,000 | 450,000 | ||
| 2022-09-01 | Smith Martin Alexander Executive Vice President | Exercise or conversion | +19 | 49 |
Page 53 of 74 · 1,474 trades